>

Healthcare & Life-Sciences Data Tools — FDA, CMS, Clinical & Provider Intelligence

Reading Time: 7 minutes

Reading Time: 9 minutes

Healthcare & Life-Sciences Data Tools — FDA, CMS, Clinical & Provider Intelligence

This page indexes structured data feeds for US healthcare and life-sciences public records — drug approvals and safety events, medical-device clearances and recalls, drug shortages, biologic and biosimilar patents, physician-payment disclosures, provider registries, and biomedical literature. The underlying data is what regulatory-affairs teams, pharmacovigilance and drug-safety analysts, medical-affairs and commercial teams, market-access researchers, life-sciences investors, journalists, and healthcare AI builders would otherwise gather by manually refreshing FDA, CMS, and NIH websites: Drugs@FDA approval records, FAERS and MAUDE adverse-event reports, the FDA recall and drug-shortage databases, the Orange Book and Purple Book, FDA 510(k) device clearances, CMS Open Payments (Sunshine Act) disclosures, the NPPES NPI provider registry, and PubMed citations. Treating these as scheduled, structured feeds rather than browser bookmarks is straightforward to justify: government portals are inconsistently designed, paginated, and rate-limited, and downstream regulatory, safety, and commercial workflows need the data shaped the same way every day. The tools below ship clean JSON or CSV with source references preserved, on whatever cadence your pipeline needs.

What’s in this category

The feeds in this hub fall into five families. Drug and FDA safety and approvals covers new-drug and biologic approvals, post-market adverse events (FAERS for drugs, MAUDE for devices), recalls, active drug shortages, general openFDA drug lookups, and the two reference registries every regulatory team relies on — the Orange Book (small-molecule patents and exclusivity) and the Purple Book (biologics and biosimilars). Medical devices covers FDA 510(k) clearances and device recalls. Providers, payments and practices covers CMS Open Payments (Sunshine Act transfers of value) and the national NPI provider registry. Clinical and research covers PubMed biomedical literature search. And healthcare MCP servers package these government sources behind a single agent-ready endpoint so an AI assistant can query them in natural language. Everything here is factual public data published by the FDA, CMS, or NIH — no patient-identifying information is involved.

Common use cases

  • Daily FDA safety brief. Pull new drug approvals, fresh recalls, and newly listed drug shortages every morning into one consolidated report for regulatory-affairs and pharmacovigilance teams.
  • Pharmacovigilance surveillance. Ingest FAERS drug adverse-event reports and MAUDE device reports on a schedule to support periodic safety review and post-market surveillance workflows.
  • Patent-cliff and exclusivity mapping. Combine Orange Book patent and exclusivity data with Purple Book biologic/biosimilar records to map when competition can enter for a given molecule.
  • Medical-device landscape tracking. Follow FDA 510(k) clearances and device recalls by product code or manufacturer to watch competitor entries and safety actions.
  • Transparency and compliance monitoring. Aggregate CMS Open Payments disclosures to review manufacturer-to-physician transfers of value, joined against the NPI registry for clean provider identity.
  • Provider and practice targeting. Build clean, de-duplicated lists of US physicians and practices from the NPI registry for market-access, field-force, and referral-network analysis.
  • Literature monitoring. Track new PubMed citations for a drug, indication, mechanism, or author to keep medical-affairs and R&D teams current.
  • Agent-driven research. Let an internal LLM assistant answer natural-language questions across FDA, NIH, CMS, and CDC sources through a single MCP endpoint.

Featured tools

Drug & FDA safety and approvals

  • 💊 FDA Drug Approvals Tracker — new and historical drug and biologic approvals from Drugs@FDA: application numbers, sponsors, approval dates, dosage forms, and routes. Pay-per-result at $0.15 per approval. Best for regulatory-affairs, competitive-intelligence, and market-access teams.
  • FDA Adverse Events Tracker — FAERS Drugs + MAUDE Devices — post-market adverse-event reports from the FDA Adverse Event Reporting System (drugs) and MAUDE (devices), in the FDA’s de-identified public form. $0.10 per event. Best for pharmacovigilance and drug-safety teams.
  • ⚠️ FDA Recall Monitor — drug, device, and food recall notices with classification, reason, recalling firm, and status. $0.05 per recall. Best for quality, supply-chain, and compliance monitoring.
  • 💊 FDA Drug Shortages Monitor — the FDA’s current and resolved drug-shortage list: product, reason, estimated resolution, and status. $0.10 per result. Best for hospital pharmacy, supply-chain, and procurement teams.
  • 💊 OpenFDA Drug Search — general-purpose lookups across openFDA drug endpoints (labeling, NDC, enforcement) for flexible querying. $0.05 per result. Best for developers and analysts building custom drug-data pipelines.
  • 🟠 FDA Orange Book — Approved Drug Products with Therapeutic Equivalence Evaluations: patents, exclusivity, and therapeutic-equivalence codes for small-molecule drugs. $0.10 per result. Best for patent-cliff analysis and generic-entry timing.
  • 🟣 FDA Purple Book — the FDA’s database of licensed biological products, including biosimilar and interchangeable records with reference-product links. $0.10 per result. Best for biologics strategy and biosimilar competition mapping.

Medical devices

  • Medical Device Intelligence — FDA 510(k) — FDA 510(k) premarket clearances and device recalls: applicant, product code, decision, clearance date, and recall history. $0.15 per device record. Best for device competitive intelligence and regulatory strategy.

Providers, payments & practices

  • 💉 CMS Open Payments Pro — Sunshine Act transfers of value joined to the NPI registry for clean physician identity: payer, amount, nature of payment, and provider details. $0.15 per result. Best for compliance, transparency, and medical-affairs analytics.
  • 💊 CMS Open Payments Scraper — raw pharma-to-doctor payment disclosures from CMS Open Payments: manufacturer, recipient, amount, and category. $0.05 per result. Best for journalists, researchers, and transparency projects.
  • 🏥 NPI Healthcare Provider Leads — US doctors and practices from the NPPES NPI registry: name, NPI, taxonomy/specialty, practice address, and enumeration data. $0.10 per result. Best for market-access, field-force planning, and referral-network mapping.

Clinical & research

  • 🔬 PubMed Research Search — medical and life-sciences papers from PubMed/MEDLINE: title, authors, journal, publication date, abstract, and identifiers. $0.05 per result. Best for medical-affairs, R&D, and literature-monitoring workflows.

Healthcare MCP servers (for AI agents)

  • Healthcare & FDA Intelligence MCP — an MCP server that lets an AI agent query FDA, NIH, CMS, and CDC sources in natural language through one endpoint. $0.05 per result. Best for wiring healthcare data into Claude, ChatGPT, or a custom LLM workflow.
  • Healthcare & Medical Data MCP Server — a broader medical-data MCP server exposing public healthcare datasets to AI agents. $0.04 per result. Best for agent builders who want medical reference data on tap.

Workflow example — daily FDA safety and shortage brief

A worked example for a regulatory-affairs and pharmacovigilance team that wants one consolidated report in a shared Drive folder each morning, covering the prior 24 hours of FDA drug approvals, recalls, and newly listed drug shortages relevant to the team’s product portfolio.

  1. Schedule the pulls at 06:45 local. In Apify, set scheduled runs for the FDA Drug Approvals Tracker, the FDA Recall Monitor, and the FDA Drug Shortages Monitor, each filtered to the prior 24 hours and the products or therapeutic areas on your watchlist.
  2. Route output to a shared dataset. Each actor writes to its own Apify dataset; an Apify webhook fires on run-finished and POSTs to a small AWS Lambda (or Cloudflare Worker) that appends records to a single Google Sheet with a normalized schema: source, record_type, product_name, company, event_date, status, source_reference.
  3. Deduplicate and join against the portfolio. A SQL view (or a single Sheets QUERY formula) drops duplicates on source reference and inner-joins the result against the team’s product list — so the morning brief only surfaces items that intersect with molecules the team actually owns or competes with.
  4. Deliver to the standup channel. A Slack incoming-webhook posts the filtered list to #reg-safety-brief at 07:30 with one line per item — source, product, event type, and a reference to the originating FDA record. Analysts triage in the standup; anything material opens a task in the team’s tracker.

Expected cost for this pipeline at a typical portfolio scale is single-digit dollars per month in Apify pay-per-result charges, plus whatever your team already pays for the Sheet, Lambda, and Slack workspace. The same pattern extends to FAERS/MAUDE surveillance, Open Payments monitoring, or PubMed literature alerts by swapping in the relevant actor.

Related categories

Frequently asked questions

How current is the data?

Refresh cadence is per-source. FDA datasets (drug approvals, FAERS adverse events, MAUDE device reports, recalls, drug shortages, Orange Book, Purple Book, 510(k) clearances) refresh on the FDA’s own publication schedule — recalls and shortages update frequently, while quarterly datasets like FAERS update each quarter. CMS Open Payments (Sunshine Act) refreshes annually with periodic corrections, and the NPI registry updates weekly. PubMed is updated continuously as new citations are indexed. Pull frequency on your side is whatever you configure in an Apify schedule — hourly, daily, or on-demand.

Is this official FDA and CMS data?

Yes. Every record originates from a public government source: the FDA (openFDA APIs, Drugs@FDA, FAERS, MAUDE, the 510(k) database, the Orange Book, the Purple Book, and the drug-shortage and recall databases), CMS (Open Payments and the NPPES NPI registry), and the NIH (PubMed/MEDLINE). The tools do not editorialize or re-score the data; they reshape the government’s own published records into clean JSON or CSV and preserve source references so you can re-derive any record from the originating agency on demand.

Can an AI agent pull this data automatically?

Yes. Most actors expose an OpenAPI surface, and two dedicated MCP servers — the Healthcare & FDA Intelligence MCP and the Healthcare & Medical Data MCP Server — let a Claude, ChatGPT, or custom LLM agent query FDA, NIH, CMS, and CDC sources in natural language. Actors that support the x402 payment standard can be called and paid for autonomously by an agent on a per-result basis, so an agent can retrieve exactly the records it needs without a human provisioning a subscription first.

Does any of this contain patient data or PHI?

No. Every source here is public aggregate or registry data. FDA adverse-event and device reports are published in de-identified form by the FDA itself; approvals, recalls, shortages, patents, and biosimilar records describe products, not patients; CMS Open Payments describes payments from manufacturers to physicians and teaching hospitals; the NPI registry lists provider business information; and PubMed lists published research citations. None of these datasets contain patient-identifying health information, so there is no HIPAA-protected PHI to handle. They are the same public disclosures the agencies publish on their own websites.

What’s the pricing model?

Apify pay-per-result. You pay only for the records returned — typically fractions of a cent to a few cents each, for example $0.15 per drug approval, $0.10 per adverse-event record, $0.05 per recall, or $0.05 per PubMed result. There is no monthly minimum and no per-seat license. A daily FDA recall-and-shortage brief costs single-digit dollars per month; a continuous provider or Open Payments enrichment run scales with the number of records you request. Detailed pricing is on each actor’s page.

Latest additions

Factual public data — not medical, legal, or investment advice.